Compound Profiles
GHRP-2
Growth Hormone Releasing Peptide-2 | Pralmorelin
GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.
Sermorelin
GHRH Analog | Growth Hormone Releasing Hormone
Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take GHRP-2 with Sermorelin?
Yes, GHRP-2 and Sermorelin can generally be taken together. Combined GHRH+GHRP-2 produces 54-fold GH increases compared to 20-fold with GHRH alone.
Is GHRP-2 and Sermorelin safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between GHRP-2 and Sermorelin?
Combined GHRH+GHRP-2 produces 54-fold GH increases compared to 20-fold with GHRH alone. This assessment has 95% confidence and is based on documented research data.
How should I time GHRP-2 and Sermorelin?
GHRP-2 has a half-life of ~30 minutes and Sermorelin has a half-life of 10-12 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.